Company registration number 01790882 (England and Wales)
WESSINGTON CRYOGENICS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
WESSINGTON CRYOGENICS LIMITED
CONTENTS
Page
Company information
1
Strategic report
2 - 3
Directors' report
4 - 5
Independent auditor's report
6 - 8
Statement of comprehensive income
9
Balance sheet
10
Statement of changes in equity
11
Notes to the financial statements
12 - 25
WESSINGTON CRYOGENICS LIMITED
COMPANY INFORMATION
- 1 -
Directors
Mr S Callion
Mr C Robertson CBE
Mr P Rowe
Mr C Nesom
(Appointed 25 August 2025)
Mr D Easton
(Appointed 25 August 2025)
Company number
01790882
Registered office
2 Gadwall Road
Rainton Bridge South
Houghton Le Spring
Tyne & Wear
England
DH4 5NL
Auditor
Consilium Audit Limited
169 West George Street
Glasgow
Scotland
G2 2LB
WESSINGTON CRYOGENICS LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -

The directors present the strategic report for the year ended 31 December 2024.

Executive Summary

The directors are pleased to report the financial results for Wessington Cryogenics Limited. In the 12 months to the end of December 2024 the company generated revenues of £20.1m compared to £16.7m in 2023, representing growth of 20% year on year. This growth was underpinned by increased production capacity, strong customer demand, and the execution of our continuous improvement agenda.

As we reflect on 2024 it is clear that the company enjoyed a period of favourable market conditions, with demand increasing across all our major product lines.

In contrast, 2025 has been a much more difficult trading environment with many of our customers in the Oil & Gas sector delaying capital expenditure, and the uncertainty around US tariffs creating significant headwinds for the business.

Wessington also suffered the loss of a long-standing customer who entered financial difficulty, resulting in both a bad debt and stock write-off. While this had a short-term impact on profit and cash performance, robust financial controls and prompt management action minimised further exposure.

Principal risks and uncertainties

The management of the business and the execution of the company's strategy are subject to several risks.

Environment

The company recognises its responsibility to promote the use of sustainable materials and to conduct its operations whilst minimising environmental impacts. The directors' continued aim is to comply with all applicable environmental legislation, prevent pollution and reduce waste wherever possible.

Health and Safety

The company is committed to achieving the highest practicable standards in health and safety management and strives to make its sites and offices safe environments for employees and customers alike.

Human Resources

The company's most important resource is its people, their knowledge and experience is crucial to meeting customer requirements. Retention of key staff is critical, and the company has invested increasingly in employment training and development and has introduced appropriate incentives and career progression arrangements.

Financial risk management

The company's operations expose it to a variety of financial risks that include the effect of changes in price risk, liquidity risk, foreign currency risk and interest rate risk.

Cybersecurity risk

The company recognises that there are cyber security risks that could affect the company, and these are managed at a company level.

Liquidity risk

The group actively maintains a mixture of long term and short-term debt finance that is designed to ensure that the company has sufficient available funds for operations and planned expansions.

Foreign currency risk

While the greater part of the group's revenues and expenses are denominated in sterling, the group is exposed to some foreign exchange risk in the normal course of business. While the group has not used financial instruments to date to hedge foreign exchange exposure, this position is kept constantly under review.

WESSINGTON CRYOGENICS LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
Development and performance

The directors are delighted to note the completion of projects that demonstrate our engineering capabilities, such as the bulk hydrogen storage vessel for the aviation industry and the supply of specialist bulk ISO tanks to transport rare materials from USA to Europe without loss or contamination.

On behalf of the board

Mr C Robertson CBE
Director
17 November 2025
WESSINGTON CRYOGENICS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the company continued to be that of manufacturing and selling storage vessels and accessories to the cryogenics industry.

Results and dividends

The results for the year are set out on page 9.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr S Callion
Mr C Robertson CBE
Mr P Rowe
Mr C Nesom
(Appointed 25 August 2025)
Mr D Easton
(Appointed 25 August 2025)
Auditor

The auditor, Consilium Audit Limited, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

WESSINGTON CRYOGENICS LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 5 -
On behalf of the board
Mr C Robertson CBE
Director
17 November 2025
WESSINGTON CRYOGENICS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF WESSINGTON CRYOGENICS LIMITED
- 6 -
Opinion

We have audited the financial statements of Wessington Cryogenics Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

WESSINGTON CRYOGENICS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF WESSINGTON CRYOGENICS LIMITED
- 7 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

 

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

 

 

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence.

 

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

WESSINGTON CRYOGENICS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF WESSINGTON CRYOGENICS LIMITED
- 8 -

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Andrew McKay
Senior Statutory Auditor
For and on behalf of Consilium Audit Limited
Statutory Auditor
169 West George Street
Glasgow
Scotland
G2 2LB
17 November 2025
WESSINGTON CRYOGENICS LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
2024
2023
Notes
£
£
Turnover
2
20,101,983
16,733,829
Cost of sales
(13,617,229)
(11,892,392)
Gross profit
6,484,754
4,841,437
Administrative expenses
(4,773,949)
(4,229,103)
Other operating income
127,388
41,016
Exceptional item
3
(1,362,655)
-
0
Operating profit
4
475,538
653,350
Interest receivable and similar income
7
32
133
Interest payable and similar expenses
8
(155,419)
(24,393)
Profit before taxation
320,151
629,090
Tax on profit
9
(45,002)
360,254
Profit for the financial year
275,149
989,344

The profit and loss account has been prepared on the basis that all operations are continuing operations.

The notes on pages 12 to 25 form part of these financial statements.

WESSINGTON CRYOGENICS LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 10 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
10
1,391,342
1,240,332
Tangible assets
11
1,169,866
995,329
2,561,208
2,235,661
Current assets
Stocks
12
4,676,392
4,015,838
Debtors
13
2,363,711
2,627,031
Cash at bank and in hand
348,210
44,484
7,388,313
6,687,353
Creditors: amounts falling due within one year
14
(5,603,554)
(6,767,976)
Net current assets/(liabilities)
1,784,759
(80,623)
Total assets less current liabilities
4,345,967
2,155,038
Creditors: amounts falling due after more than one year
15
(142,061)
(226,281)
Net assets
4,203,906
1,928,757
Capital and reserves
Called up share capital
21
3,030,000
1,030,000
Profit and loss reserves
1,173,906
898,757
Total equity
4,203,906
1,928,757

The notes on pages 12 to 25 form part of these financial statements.

The financial statements were approved by the board of directors and authorised for issue on 17 November 2025 and are signed on its behalf by:
Mr S Callion
Mr C Robertson CBE
Director
Director
Company Registration No. 01790882
WESSINGTON CRYOGENICS LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 11 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2023
1,030,000
(90,587)
939,413
Year ended 31 December 2023:
Profit and total comprehensive income for the year
-
989,344
989,344
Balance at 31 December 2023
1,030,000
898,757
1,928,757
Year ended 31 December 2024:
Profit and total comprehensive income for the year
-
275,149
275,149
Conversion of loan to shares
21
2,000,000
-
2,000,000
Balance at 31 December 2024
3,030,000
1,173,906
4,203,906

The notes on pages 12 to 25 form part of these financial statements.

WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 12 -
1
Accounting policies
Company information

Wessington Cryogenics Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2 Gadwall Road, Rainton Bridge South, Houghton Le Spring, Tyne & Wear, England, DH4 5NL. The company's registration number is 01790882.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of RCI Trading Group Limited. These consolidated financial statements are available from its registered office.

1.2
Going concern

As mentioned in the Strategic Report, the company has suffered from a difficult trading environment post year-end with a significant reduction in revenue from the year to December 2024true. Although the company continues to have a strong balance sheet, Robertson Campbell Investments Limited, a related entity, has pledged its support to the Company to enable it to continue in operational existence for the foreseeable future.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 13 -
1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.5
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Development costs
10% straight line

Capitalised development expenditure is amortised over its useful life of 10 years. The directors consider this useful life to be a reasonable estimate of the period over which the product will generate income.

1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
over the lease term
Plant and equipment
10% reducing balance
Fixtures and fittings
15% straight line / 33% straight line
Motor vehicles
10% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit and loss account.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 14 -

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in the profit and loss account. Reversals of impairment losses are also recognised in the profit and loss account.

1.9
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in the profit and loss account, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through the profit and loss account are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the profit and loss account.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in the profit and loss account.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 15 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in the profit and loss account in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through the profit and loss account. Debt instruments may be designated as being measured at fair value through the profit and loss account to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.11
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.12
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 16 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.13
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.14
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.15
Leases

Assets held under hire purchase agreements are capitalised and disclosed under tangible fixed assets at their fair value, and are depreciated in accordance with the above depreciation policies.

 

Future instalments payable under such agreements, net of finance charges, are included within creditors. Rentals payable are apportioned between the capital element, which reduces the outstanding obligation included within creditors, and the finance element, which is charged to the profit and loss account on a straight line basis.

Rentals payable under operating leases, including any lease incentives received, are charged to the profit and loss account on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.16
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 17 -
1.17
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in the profit and loss account.

2
Turnover and other revenue
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
5,741,409
2,583,698
Europe
6,299,619
3,560,032
Rest of the World
8,060,955
10,590,099
20,101,983
16,733,829
2024
2023
£
£
Other revenue
Interest income
32
133
Grants received
112,944
35,331
3
Exceptional item
2024
2023
£
£
Expenditure
Stock and bad debt provision relating to termination of project
1,362,655
-

The exceptional items noted above represent one off costs and loss of sales related to an individual customer project which has terminated subsequent to the year-end. The impact of this has been assessed by the directors and accounted for as an adjusting post balance sheet event.

 

4
Operating profit
2024
2023
Operating profit for the year is stated after charging/(crediting):
£
£
Exchange losses
19,063
31,737
Government grants
(112,944)
(35,331)
Fees payable to the company's auditor for the audit of the company's financial statements
25,950
25,000
Depreciation of owned tangible fixed assets
229,096
122,564
Depreciation of tangible fixed assets held under finance leases
8,585
6,747
Amortisation of intangible assets
205,726
175,515
Operating lease charges
32,513
20,730
WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 18 -
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
142
130

Their aggregate remuneration comprised:

2024
2023
£
£
Wages and salaries
5,705,090
4,499,795
Social security costs
728,418
605,370
Pension costs
78,299
73,019
6,511,807
5,178,184
6
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
109,075
86,051
7
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest on bank deposits
32
133
8
Interest payable and similar expenses
2024
2023
£
£
Interest on bank overdrafts and loans
282
59
Interest on finance leases and hire purchase contracts
2,908
2,025
Other interest
152,229
22,309
155,419
24,393
WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 19 -
9
Taxation
2024
2023
£
£
Current tax
Benefit arising from a previously unrecognised tax loss or credit
(311,537)
-
0
Deferred tax
Origination and reversal of timing differences
356,539
(360,254)
Total tax charge/(credit)
45,002
(360,254)

The actual charge/(credit) for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Profit before taxation
320,151
629,090
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
80,038
147,962
Tax effect of expenses that are not deductible in determining taxable profit
12,090
3,806
Unutilised tax losses carried forward
445,388
234,324
Research and development enhanced deduction
(530,789)
(382,151)
Movement on deferred tax
356,539
(360,254)
Research and development tax credit
(311,537)
-
0
Other movements
(6,727)
(3,941)
Taxation charge/(credit) for the year
45,002
(360,254)
WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 20 -
10
Intangible fixed assets
Development costs
£
Cost
At 1 January 2024
2,057,196
Additions - internally developed
356,736
At 31 December 2024
2,413,932
Amortisation and impairment
At 1 January 2024
816,864
Amortisation charged for the year
205,726
At 31 December 2024
1,022,590
Carrying amount
At 31 December 2024
1,391,342
At 31 December 2023
1,240,332

The directors have assessed the carrying value of the capitalised development costs and are satisfied that these assets are not impaired.

11
Tangible fixed assets
Leasehold land and buildings
Plant and equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 January 2024
121,104
1,473,569
179,925
67,465
1,842,063
Additions
-
0
367,431
56,296
-
0
423,727
Disposals
-
0
-
0
(23,018)
-
0
(23,018)
At 31 December 2024
121,104
1,841,000
213,203
67,465
2,242,772
Depreciation and impairment
At 1 January 2024
121,104
643,353
69,914
12,363
846,734
Depreciation charged in the year
-
0
180,783
50,151
6,747
237,681
Eliminated in respect of disposals
-
0
-
0
(11,509)
-
0
(11,509)
At 31 December 2024
121,104
824,136
108,556
19,110
1,072,906
Carrying amount
At 31 December 2024
-
0
1,016,864
104,647
48,355
1,169,866
At 31 December 2023
-
0
830,216
110,011
55,102
995,329
WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
11
Tangible fixed assets
(Continued)
- 21 -

The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.

2024
2023
£
£
Fixtures and fittings
71,663
-
0
Motor vehicles
48,350
55,096
120,013
55,096
12
Stocks
2024
2023
£
£
Raw materials and consumables
3,036,700
2,544,640
Work in progress
1,639,692
1,471,198
4,676,392
4,015,838
13
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
1,596,583
1,905,866
Corporation tax recoverable
322,604
4,348
Other debtors
200,747
145,635
Prepayments and accrued income
243,777
218,254
2,363,711
2,274,103
Deferred tax asset (note 18)
-
0
352,928
2,363,711
2,627,031
WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 22 -
14
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Bank loans
16
34,735
71,306
Obligations under finance leases
17
28,622
13,384
Trade creditors
2,732,872
3,748,362
Amounts owed to group undertakings
41,442
2,014,827
Amounts owed to related parties
1,659,847
-
0
Taxation and social security
99,111
121,306
Government grants
19
23,332
23,332
Other creditors
460,981
441,822
Accruals and deferred income
522,612
333,637
5,603,554
6,767,976

The finance leases above relate to hire purchase agreements. These liabilities are secured over the individual assets to which they relate.

 

Loans are secured by a fixed and floating charge over the assets of the company.

 

Included within other creditors is a loan from a shareholder of £319,167 (2023: £295,103). This loan attracts interest at 2.8%.

15
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Bank loans and overdrafts
16
-
0
33,554
Obligations under finance leases
17
71,694
30,874
Government grants
19
70,367
103,215
Other creditors
-
0
58,638
142,061
226,281
16
Loans and overdrafts
2024
2023
£
£
Bank loans
34,735
104,860
Payable within one year
34,735
71,306
Payable after one year
-
0
33,554

 

The bank loan relates to a CBILS loan. Interest is payable at 9%.

WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 23 -
17
Finance lease obligations
2024
2023
Future minimum lease payments due under finance leases:
£
£
Within one year
28,622
13,384
In two to five years
71,694
30,874
100,316
44,258

 

18
Deferred taxation

The following are the major deferred tax liabilities recognised by the company and movements thereon:

Assets
Assets
2024
2023
Balances:
£
£
Accelerated capital allowances
(628,321)
(456,077)
Tax losses
612,557
793,241
Revaluations
14,427
14,427
Retirement benefit obligations
1,337
1,337
-
352,928
2024
Movements in the year:
£
Asset at 1 January 2024
(352,928)
Charge to profit or loss
356,539
Other
(3,611)
Liability at 31 December 2024
-

The company has an unrecognised deferred tax asset of £1.2m as at 31 December 2024. This was not recognised due to uncertainty over the timing of the recoverability of the asset. Overall tax losses at 31 December 2024 were £5,516,763.

 

In the year to 31 December 2024, the company has continued to trade profitability however post year-end trade has suffered a downturn. The Directors have performed an exercise to assess the recoverability of the deferred tax asset over a reasonable timeframe and have taken the decision to reduce the deferred tax asset to £nil.

WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 24 -
19
Government grants
2024
2023
£
£
Arising from government grants
93,699
126,547
Included in the financial statements as follows:
Current liabilities
23,332
23,332
Non-current liabilities
70,367
103,215
93,699
126,547
20
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
78,299
73,019

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

21
Share capital
2024
2023
£
£
Ordinary share capital
Issued and fully paid
3,029,997 (2023: 1,029,997) Ordinary of £1
3,029,997
1,029,997
1 Ordinary "A" of £1
1
1
1 Ordinary "B" of £1
1
1
1 Ordinary "C" of £1
1
1
3,030,000
1,030,000

Ordinary shares rank pari passu with each other.

 

During the year a loan from the parent company was capitalised with 2 million ordinary shares of £1 being issued at par.

WESSINGTON CRYOGENICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 25 -
22
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2024
2023
£
£
Within one year
420,019
420,019
Between two and five years
1,338,144
1,338,144
In over five years
813,750
813,750
2,571,913
2,571,913
23
Related party transactions

The company has taken advantage of exemption under the terms of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland", not to disclose related party transactions with wholly owned subsidiaries within the group.

 

No further transactions with related parties were undertaken such as are required to be disclosed under the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".

24
Ultimate controlling party

The immediate parent company is Wessington Topco Limited.

The ultimate parent company is RCI Trading Group Limited.

The ultimate controlling party is Mr C Robertson by virtue of his shareholding in the ultimate parent company.

2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.200Mr S CallionMr P RoweMr C NesomMr D EastonMr D Easton017908822024-01-012024-12-3101790882bus:Director12024-01-012024-12-3101790882bus:Chairman2024-01-012024-12-3101790882bus:Director22024-01-012024-12-3101790882bus:Director32024-01-012024-12-3101790882bus:Director42024-01-012024-12-3101790882bus:Director52024-01-012024-12-3101790882bus:RegisteredOffice2024-01-012024-12-31017908822024-12-31017908822023-01-012023-12-310179088212024-01-012024-12-310179088212023-01-012023-12-3101790882core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3101790882core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3101790882core:OtherResidualIntangibleAssets2024-12-3101790882core:OtherResidualIntangibleAssets2023-12-3101790882core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-3101790882core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-31017908822023-12-3101790882core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-12-3101790882core:PlantMachinery2024-12-3101790882core:FurnitureFittings2024-12-3101790882core:MotorVehicles2024-12-3101790882core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-12-3101790882core:PlantMachinery2023-12-3101790882core:FurnitureFittings2023-12-3101790882core:MotorVehicles2023-12-3101790882core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3101790882core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3101790882core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3101790882core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3101790882core:CurrentFinancialInstruments2024-12-3101790882core:CurrentFinancialInstruments2023-12-3101790882core:Non-currentFinancialInstruments2024-12-3101790882core:Non-currentFinancialInstruments2023-12-3101790882core:ShareCapital2024-12-3101790882core:ShareCapital2023-12-3101790882core:RetainedEarningsAccumulatedLosses2024-12-3101790882core:RetainedEarningsAccumulatedLosses2023-12-3101790882core:ShareCapital2022-12-3101790882core:RetainedEarningsAccumulatedLosses2022-12-3101790882core:ShareCapitalOrdinaryShareClass12024-12-3101790882core:ShareCapitalOrdinaryShareClass12023-12-3101790882core:ShareCapitalOrdinaryShareClass22024-12-3101790882core:ShareCapitalOrdinaryShareClass22023-12-3101790882core:ShareCapitalOrdinaryShareClass32024-12-3101790882core:ShareCapitalOrdinaryShareClass32023-12-3101790882core:ShareCapitalOrdinaryShareClass42024-12-3101790882core:ShareCapitalOrdinaryShareClass42023-12-3101790882core:ShareCapitalOrdinaryShares2024-12-3101790882core:ShareCapitalOrdinaryShares2023-12-3101790882core:ShareCapital2024-01-012024-12-3101790882core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3101790882core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-012024-12-3101790882core:LandBuildingscore:LongLeaseholdAssets2024-01-012024-12-3101790882core:PlantMachinery2024-01-012024-12-3101790882core:FurnitureFittings2024-01-012024-12-3101790882core:MotorVehicles2024-01-012024-12-3101790882core:UKTax2024-01-012024-12-3101790882core:UKTax2023-01-012023-12-310179088222024-01-012024-12-310179088222023-01-012023-12-310179088232024-01-012024-12-310179088232023-01-012023-12-3101790882core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-3101790882core:DevelopmentCostsCapitalisedDevelopmentExpenditurecore:InternallyGeneratedIntangibleAssets2024-01-012024-12-3101790882core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-12-3101790882core:PlantMachinery2023-12-3101790882core:FurnitureFittings2023-12-3101790882core:MotorVehicles2023-12-31017908822023-12-3101790882core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-01-012024-12-3101790882core:Non-currentFinancialInstruments12024-12-3101790882core:Non-currentFinancialInstruments12023-12-3101790882core:WithinOneYear2024-12-3101790882core:WithinOneYear2023-12-3101790882core:BetweenTwoFiveYears2024-12-3101790882core:BetweenTwoFiveYears2023-12-3101790882core:MoreThanFiveYears2024-12-3101790882bus:PrivateLimitedCompanyLtd2024-01-012024-12-3101790882bus:FRS1022024-01-012024-12-3101790882bus:Audited2024-01-012024-12-3101790882bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP